Safety and Clinical Tolerability of hdmASIT+TM Peptides Administered in HDM-induced Allergic Patients

NCT03094845 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

House Dust Mite Allergy

Interventions

BIOLOGICAL: Placebo solution
BIOLOGICAL: hdmASIT+TM

Sponsor

ASIT Biotech S.A.